| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,152,000 |
| Market
Cap: |
3.31(B) |
| Last
Volume: |
218,504 |
Avg
Vol: |
307,925 |
| 52
Week Range: |
$56.28 - $75.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 821 |
| Guru Rank Value : 0.6 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, marketing, sales, and distribution of over-the-counter (OTC) health and personal care products. Co. conducts its operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare. Co.'s brands in the North American OTC Healthcare segment include Boudreaux's Butt Paste with products that include various diaper rash treatments and skin protectants. Co.'s brands in the International OTC Healthcare segment include Fess that relieves nasal and sinus congestion due to allergy, hay fever, colds and flu.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
10,535 |
87,458 |
178,092 |
277,989 |
| Total Sell Value |
$741,926 |
$6,003,294 |
$11,624,998 |
$17,686,973 |
| Total People Sold |
1 |
4 |
5 |
5 |
| Total Sell Transactions |
5 |
9 |
12 |
18 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Parkinson John |
Senior VP- International |
• – – |
2013-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,800 |
46,133 |
|
- |
|
| Connors Timothy |
EVP, Sales & Marketing |
• – – |
2013-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,855 |
73,069 |
|
- |
|
| Cowley Samuel C |
General Counsel, VP Bus Dev. |
• – – |
2013-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
9,033 |
17,467 |
|
- |
|
| Boyko Jean A |
SVP, Science and Technology |
• – – |
2013-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,529 |
24,699 |
|
- |
|
| Parkinson John |
Senior VP- International |
• – – |
2013-04-08 |
4 |
D |
$25.96 |
$96,779 |
D/D |
(3,728) |
51,713 |
|
- |
|
| Byom John E |
Director |
– • – |
2013-02-19 |
4 |
S |
$24.36 |
$365,400 |
D/D |
(15,000) |
22,020 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2013-02-13 |
4 |
S |
$24.05 |
$788,960 |
I/I |
(32,805) |
69,424 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2013-02-13 |
4 |
OE |
$7.16 |
$234,884 |
I/I |
32,805 |
102,229 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2013-02-12 |
4 |
S |
$24.06 |
$1,015,212 |
I/I |
(42,195) |
69,424 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2013-02-12 |
4 |
OE |
$7.16 |
$302,116 |
I/I |
42,195 |
111,619 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
69,424 |
69,424 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-12-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
69,424 |
0 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
69,924 |
118,609 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-12-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
69,424 |
69,424 |
|
- |
|
| Lonergan Patrick |
Director |
– • – |
2012-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
37,323 |
|
- |
|
| Connors Timothy |
EVP, Sales & Marketing |
• – – |
2012-12-05 |
4 |
S |
$20.33 |
$343,577 |
D/D |
(16,900) |
50,214 |
|
- |
|
| Connors Timothy |
EVP, Sales & Marketing |
• – – |
2012-12-05 |
4 |
OE |
$9.45 |
$159,705 |
D/D |
16,900 |
67,114 |
|
- |
|
| Connors Timothy |
EVP, Sales & Marketing |
• – – |
2012-12-04 |
4 |
S |
$20.35 |
$554,761 |
D/D |
(27,261) |
50,214 |
|
- |
|
| Connors Timothy |
EVP, Sales & Marketing |
• – – |
2012-12-04 |
4 |
OE |
$9.45 |
$257,616 |
D/D |
27,261 |
77,475 |
|
- |
|
| Boyko Jean A |
SVP, Science and Technology |
• – – |
2012-11-28 |
4 |
S |
$12.32 |
$380,639 |
D/D |
(30,896) |
22,170 |
|
- |
|
| Boyko Jean A |
SVP, Science and Technology |
• – – |
2012-11-28 |
4 |
OE |
$10.91 |
$380,748 |
D/D |
30,896 |
53,066 |
|
- |
|
| Hennessey Paul A. |
Vice President, Operations |
• – – |
2012-11-26 |
4 |
S |
$20.88 |
$190,614 |
D/D |
(9,129) |
13,282 |
|
- |
|
| Hennessey Paul A. |
Vice President, Operations |
• – – |
2012-11-26 |
4 |
OE |
$11.27 |
$102,884 |
D/D |
9,129 |
22,411 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-11-20 |
4 |
S |
$20.71 |
$3,241,011 |
D/D |
(156,495) |
188,533 |
|
- |
|
| Mannelly Matthew |
President and CEO |
• • – |
2012-11-20 |
4 |
OE |
$7.16 |
$1,120,504 |
D/D |
156,495 |
345,028 |
|
- |
|
756 Records found
|
|
Page 19 of 31 |
|
|
0.32 (0.49%) 
